Y-Intercept (HK)’s RxSight RXST Stock Holding History

Y-Intercept (HK)’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$887K	Sell	183,942 -12,993	-7%	-$78.4K	0.02%	1095
2026 Q1	$1.21M	Sell	196,935 -21,828	-10%	-$181K	0.02%	940
2025 Q4	$2.28M	Buy	218,763 +83,969	+62%	+$843K	0.05%	564
2025 Q3	$1.21M	Buy	134,794 +24,743	+22%	+$217K	0.03%	881
2025 Q2	$1.43M	Buy	+110,051	New	+$1.65M	0.04%	763
2024 Q3	–	Sell	-12,390	Closed	-$746K	–	1741
2024 Q2	$746K	Buy	12,390 +7,336	+145%	+$419K	0.04%	631
2024 Q1	$261K	Sell	5,054 -1,306	-21%	-$64.1K	0.02%	1022
2023 Q4	$256K	Buy	+6,360	New	+$187K	0.02%	884

Other funds holding RXST

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

AAG

Armstrong Advisory Group Needham, Massachusetts $1.64B AUM 19.37% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Y-Intercept (HK)'s RXST Position: Q2 2026 in Review

Y-Intercept (HK) reduced its RxSight (RXST) stake by 6.6% in Q2 2026, selling an estimated $78.4K and leaving 183,942 shares worth $887K. The position accounts for 0.02% of the portfolio, ranked #1095.

Y-Intercept (HK) first reported a position in RXST in Q4 2023 and has held it in 8 quarters since. The position peaked at $2.28M in Q4 2025. 7 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

Y-Intercept (HK) held 183,942 shares of RxSight worth $887K as of Q2 2026.
Y-Intercept (HK) sold 12,993 RxSight shares in Q2 2026, an estimated $78.4K.
RxSight made up 0.02% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1095 holding.
Y-Intercept (HK) first reported a position in RxSight in Q4 2023 and has held it in 8 quarters since.
Y-Intercept (HK)'s RxSight position peaked at $2.28M in Q4 2025.
7 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.